期刊文献+

Association of Helicobacter pylori IgA antibodies with the risk of peptic ulcer disease and gastric cancer 被引量:3

Association of Helicobacter pylori IgA antibodies with the risk of peptic ulcer disease and gastric cancer
下载PDF
导出
摘要 AIM: To compare the prevalence of Helicobacter pylori (Hpylori) IgG and IgA antibodies between adult subjects,with defined gastric diseases, nondefined gastric disorders and those representing the population.METHODS: Data on H pylori IgG and IgA antibodies,determined by enzyme immunoassay, were analyzed in 3 252 subjects with DGD including 482 patients with gastric ulcer, 882 patients with duodenal ulcer, 1 525patients with chronic gastritis only and 363 subjects with subsequent gastric cancer, 19 145 patients with NoDg and4 854 POPUL subjects. The age-adjusted prevalences were calculated for 1- and 20-year age cohorts.RESULTS: The prevalences of IgG antibodies were equally high (89-96%) in all 20-year age cohorts of the DGD groups, whereas the prevalences of IgG antibodies were lower and increased by age in the POPUL and NoDg groups. The prevalences of IgA antibodies were also higher in the DGD groups; among them CA (84-89%) and GU groups (78-91%) showed significantly higher prevalences than DU (68-77%) and CG patients (59-74%) (OR 2.49, 95%CI 1.86-3.34 between the GU and DU groups). In the CA, GU, and DU groups, the IgA prevalences showed only minor variation according to age, while they increased by age in the CG, POPUL, and NoDg groups (P≤0.0001). The IgA response, but not the IgG response, was associated with an increased risk of CA (OR 2.41, 95%CI 1.79-3.53) and GU (OR 2.57,95%CI 1.95-3.39) in comparison with CG patients.CONCLUSION: An IgA antibody response during H pylori infection is significantly more common in CA and GU patients as compared with CG patients. AIM: To compare the prevalence of Helicobacter pylori (Hpylori) IgG and IgA antibodies between adult subjects, with defined gastric diseases, nondefined gastric disorders and those representing the population. METHODS: Data on H pylori IgG and IgA antibodies, determined by enzyme immunoassay, were analyzed in 3 252 subjects with DGD including 482 patients with gastric ulcer, 882 patients with duodenal ulcer, 1 525 patients with chronic gastritis only and 363 subjects with subsequent gastric cancer, 19 145 patients with NoDg and 4 854 POPUL subjects. The age-adjusted prevalences were calculated for 1- and 20-year age cohorts. RESULTS: The prevalences of IgG antibodies were equally high (89-96%) in all 20-year age cohorts of the DGD groups, whereas the prevalences of IgG antibodies were lower and increased by age in the POPUL and NoDg groups. The prevalences of IgA antibodies were also higher in the DGD groups; among them CA (84-89%) and GU groups (78-91%) showed significantly higher prevalences than DU (68-77%) and CG patients (59-74%) (OR 2.49, 95%CI 1.86-3.34 between the GU and DU groups). In the CA, GU, and DU groups, the IgA prevalences showed only minor variation according to age, while they increased by age in the CG, POPUL, and NoDg groups (P≤〈0.0001). The IgA response, but not the IgG response, was associated with an increased risk of CA (OR 2.41, 95%CI 1.79-3.53) and GU (OR 2.57, 95%CI 1.95-3.39) in comparison with CG patients. CONCLUSION: An IgA antibody response during Hpylori infection is significantly more common in CA and GU patients as compared with CG patients.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第43期6871-6874,共4页 世界胃肠病学杂志(英文版)
基金 Supported by the University of Helsinki, the Helsinki University Central Hospital and the Finnish Cancer Organisations, Helsinki, Finland
关键词 IGA 幽门螺杆菌 胃溃疡 胃癌 Helicobacter pylori IgA antibodies Gastriccancer Gastric ulcer Duodenal ulcer Chronic gastritis
  • 相关文献

参考文献11

  • 1R. A. Feldman,J. J. Deeks,S. J. W. Evans.Multi-laboratory comparison of eight commercially availableHelicobacter pylori serology kits[J].European Journal of Clinical Microbiology & Infectious Diseases.1995(5)
  • 2Marshall BJ.Helicobacter pylori[].The American journal of Gastroenterology.1994
  • 3Marshall BJ,Armstrong JA,McGechie DB,Glancy RJ.Attempt to fulfil Koch’s postulates for pyloric Campylobacter[].Medical Journal of Australia.1985
  • 4Parsonnet J,Friedman GD,Orentreich N,Vogelman H.Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection[].Gut.1997
  • 5Infection with Helicobacter pylori. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans . 1994
  • 6Oksanen A,Veijola L,Sipponen P,Schauman KO,Rautelin H.Evaluation of Pyloriset Screen, a rapid whole-blood diagnostic test for Helicobacter pylori infection[].Journal of Clinical Microbiology.1998
  • 7Rauws EA,Tytgat GN.Cure of duodenal ulcer associated with eradication of Helicobacter pylori[].The Lancet.1990
  • 8Andersen LP,Rosenstock SJ,Bonnevie O,Jorgensen T.Seroprevalence of immunoglobulin G, M, and A antibodies to Helicobacter pylori in an unselected Danish population[].American Journal of Epidemiology.1996
  • 9Kosunen TU,Aromaa A,Knekt P,Salomaa A,Rautelin H,Lohi P,Heinonen OP.Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland[].Epidemiology and Infection.1997
  • 10Helicobacter and Cancer Collaborative Group.Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts[].Cutis.2001

同被引文献11

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部